Paid Clinical Trials West Palm Beach
Discover 579 paid clinical trials in West Palm Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
LumateperoneMulticenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
Sponsor:
Intra-Cellular Therapies, Inc.
Location:
Code:
NCT06372964
Conditions
Bipolar Depression
Eligibility Criteria
Sex: All
Age: 10 - 17
Healthy Volunteers: Not accepted
Interventions
Lumateperone
Placebo
Islatravir & LenacapavirStudy to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Standard of Care in Virologically Suppressed People With HIV-1
Sponsor:
Gilead Sciences
Location:
Code:
NCT06630299
Conditions
HIV-1-Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ISL/LEN
Antiretroviral Combinations
PEN-866PEN-866 in Patients With Advanced Solid Malignancies
Sponsor:
Tarveda Therapeutics
Location:
Code:
NCT03221400
Conditions
Carcinoma
Endometrial Adenocarcinoma
Neoplasms
Squamous Cell Carcinoma of the Anus
Adenocarcinoma of the Pancreas
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
PEN-866 Sodium
fluorouracil
Folinic acid
Niraparib
PovorcitinibA Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN1)
Sponsor:
Incyte Corporation
Location:
Code:
NCT06516952
Conditions
Prurigo Nodularis
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Povorcitinib
Placebo
Hintermann H3Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
Sponsor:
DT MedTech, LLC
Location:
Code:
NCT04770870
Conditions
Osteoarthritis Ankle
Post-Traumatic Osteoarthritis of Ankle
Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)
Eligibility Criteria
Sex: All
Age: 21+
Healthy Volunteers: Accepted
Interventions
Hintermann Series H3 Total Ankle Replacement System
Nemtabrutinib vs. Ibrutinib & AcalabrutinibA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06136559
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nemtabrutinib
Ibrutinib
Acalabrutinib
IvonescimabClinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients
Sponsor:
Summit Therapeutics
Location:
Code:
NCT05899608
Conditions
Non-Small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ivonescimab Injection
Pembrolizumab Injection
InSpaceInSpace Accelerated Rehabilitation Study
Sponsor:
Stryker Endoscopy
Location:
Code:
NCT05329584
Conditions
Rotator Cuff Tears
Eligibility Criteria
Sex: All
Age: 65+
Healthy Volunteers: Accepted
Interventions
InSpace Subacromial Tissue Spacer
IPRCT, Blinded, 2-Arm Efficacy Study of IP and Placebo in Patients With Chronic Pain Related to Osteoarthritis of the Knee
Sponsor:
Overseas Pharmaceuticals, Ltd.
Location:
Code:
NCT05318521
Conditions
Degenerative Arthritis
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Placebo
Ibuprofen modified release tablet 800 mg
BatoclimabStudy to Assess Batoclimab in Participants With Active Thyroid Eye Disease
Sponsor:
Immunovant Sciences GmbH
Location:
Code:
NCT05517421
Conditions
Thyroid Eye Disease
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Batoclimab
Placebo